The Executive Guide to Molecular Imaging
| Publication Date | July 2007 |
|---|---|
| Publisher | Espicom |
| Product Type | Report |
| Pages | 306 |
| ISBN Number | 978-1-85822-293-6 |
| Product Code | ESP00322 |
Summary
This report examines the background to the whole MI market, providing estimates and evaluation in key areas and examining in-depth the companies, innovative products and academic research that are driving change. Providing...
Comprehensive assessment of the current state of the MI markets
MI in the context of medical imaging
- Focus on MI in major clinical areas:
- Alzheimer's disease
- Cancer
- Cardiovascular
A highly-detailed examination of 53 companies actively developing MI products and technology
A review of MI research in 46 leading academic centres worldwide.
Content
- Molecular Imaging
- Molecular Imaging Modalities
- Imaging technologies - comparison of characteristics
- New MR-PET Hybrid Imaging Technology
- Imaging Biomarkers
- Drug Development
- Initiatives for the Advancement of Molecular Imaging
- Microdosing in Phase 0 Trials
- Shortening Timelines for Drug Development
- SNM
- Acrin
- Collaborative Imaging Biomarker Center
- Disease Focus - Key Areas
- Alzheimer's Disease
- ADNI Study
- Cancer
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Cardiovascular Disease
- Challenges for Molecular Imaging Product Development
- Summary - Challenges for Imaging in Clinical Trials
- Market Estimates
- Fig.1: Medical Imaging Market, 2005-2010E (EUR billion)*
- Fig.2: Medical Imaging Systems Market by Modality, 2005*
- Fig.3: Medical Imaging Systems Market by Region, 2005*
- Imaging Agent Manufacturers - 2006 Revenues*
- Fig.4. Imaging Agent Manufacturers, Market Share 2006
- Fig.5. Global Market for Imaging Agents 2005-2020, EUR Million
- Industry Highlights
- Molecular Imaging Companies
- Agenix
- ThromboView
- Recent Highlights
- ThromboView Market Forecast
- Divestitures
- Funding
- AION DIAGNOSTICS
- Molecular Imaging Candidate
- mpSi Pilot Study Results
- Hybrid Contrast Agent
- Marking Agent
- Corporate Background
- Anticancer
- Products
- MetaMouse, AngioMouse, OncoBrite and GeneBrite
- OncoBrite
- MetaMouse - AngioMouse
- Fluorescence Imaging Technology Patents
- Research and Development
- Therapeutic Product Pipeline
- Diagnostic Product Pipeline
- Agreements
- Indec Systems
- Olympus
- Roswell Park Cancer Institute
- ART ADVANCED RESEARCH TECHNOLOGIES
- eXplore Optix MX2
- Time Domain (TD) Optical Imaging Technology
- SoftScan
- Fenestra
- Development Pipeline - Second-generation Systems
- Acquisitions
- Alerion
- Dr. Joseph Lakowicz' MI Patent Portfolio
- Alliances
- GE Healthcare
- LAB Preclinical Research International
- Financials
- Financial Highlights (in US$)
- AVID RADIOPHARMACEUTICALS
- Clinical study of PET imaging with AV-1 in patients with AD
- Agreements
- MDS Nordion
- Bayer Schering Pharma AG
- Development Pipeline
- Intellectual Property
- Funding
- Bayer Schering Pharma Ag
- Licensing and Research Agreements
- Stanford University
- Taisho Pharmaceutical Co. Ltd., Nihon Nohyaku Co. Ltd., and the National Institute of Radiological Sciences, Japan
- Molecular Insight Pharmaceuticals
- Philips Medical Systems
- Financials
- Fiscal 2006
- Biomoda
- Patent Portfolio
- Bioscan
- Products
- Imaging Systems
- NanoSPECT/CT
- HiSPECT
- PET Chemistry/Nuclear Medicine
- AR-2000 Imaging Scanner
- Agreements
- Philips Medical Systems
- Biospace Med
- Molecular Imaging Activities
- In Vitro Imaging
- In Vivo Imaging
- MICROPROBE
- . IMAGER
- . IMAGER-S
- F IMAGER
- First Clinical Product - Ultra-low-Dose 2D/3D Full-body X-ray Scanning Device
- Boston Life Sciences
- Altropane - Parkinson's Disease
- Development
- Altropane - Attention Deficit Hyperactivity Disorder
- Development
- Technetium-based agents
- Imaging Approach
- Development Programme
- PET Imaging Agents
- DAT Blocker Programme
- Licensing Agreement
- BioAxone Therapeutic
- Financials
- Bracco
- Products
- Bracco Neuroimaging Clinical Trial Project
- Agreements
- VisualSonics
- Epix Pharmaceuticals
- Research and Development
- Financials
- Fiscal 2005
- Bristol-Myers Squibb Medical Imaging
- Imaging Agents
- Cardiolite
- Definity
- Miraluma
- MI Agreements
- GE Healthcare
- Kereos
- Draxis Health
- AnorMed
- ImaRx Therapeutics
- Bruker Biospin
- MRI Products
- BioSpec Series
- BioSpec 117/16 - 11.7T USR Preclinical MRI System
- BioSpec 94/30 USR - 9.4T USR Preclinical MRI System
- ClinScan 7T High Field System for Preclinical Imaging
- PharmaScan - MRI System for Pharmaceutical Industry and Biotechnology
- CryoCoils
- Customised Systems
- MedSpec 4T - Dedicated Head Scanner for Clinical & Neuroscientific Research
- ParaVision Software for Preclinical MR Imaging Research
- Ultra short echo time image of the rat lung
- Fourier Flow Imaging
- MRI CryoProbe
- New Signal-to-Noise Horizons in Small Animal MRI
- Bruker BioSpin NMR Division
- Avance III Spectrometer
- Magnet
- New project at Tbingen - 16.4T Horizontal Animal MRI Systems
- Caliper Life Sciences/Xenogen
- IVIS Imaging Systems and Living Image Software
- Living Image Software Version 2.5
- Living Image Software 3D Analysis Package
- Light Producing Cells and Microorganisms
- Light Producing Animal Models
- Reagents
- VivoFluor Fluorescence Labelling Kits
- D-Luciferin Potassium Salt
- Drug Discovery and Development Services
- Competitors
- Imaging
- Agreements
- Pfizer
- Molecular Probes
- Merck
- Taconic Farms
- Patents and Litigation
- Biophotonic Imaging Patents
- Financials
- Fiscal 2006
- Outlook for Fiscal 2007
- Cambridge Isotope Laboratories (Cil)
- Rover - Pet Evaluation Software
- Cangen Biotechnologies
- Microsatellite Analysis (MSA)
- Phase III Study
- Mass Spectrum (MS) Analysis
- Research Agreements
- Olympus
- Strategic Partners
- Johns Hopkins University
- JSR Corporation
- Cardinal Health
- Financials
- Supply Chain Services - Pharmaceutical
- First Nine Months of Fiscal 2007 to 31st March 2007 (US$ million)
- Outlook
- Cellpoint
- EC Technology
- EC Technology (8 Diagnostic Imaging Agents)
- 99mTc-EC-G
- Other EC technology Imaging Agents for SPECT
- Imaging Agents for PET Applications
- EC Technology (4 Therapeutic Agents)
- 188Re-EC-G
- In Situ Hydrogel
- N4 Technology
- Oligosaccharide Conjugates / Dual-agent Technology
- Beta Cell Technology
- Research Agreements
- Philips Medical Systems
- M. D. Anderson Cancer Center
- Business Model
- Patents
- Cytogen
- ProstaScint
- Validation of PSMA Prognostic Value
- ProstaScint Market Opportunity
- Development Pipeline
- Abtides
- Oral Drug Delivery Technology
- Clinical Trials
- CYT-500 Radiolabelled Monoclonal Antibody
- Quadramet Phase II Study - New Indication for Prostate Cancer
- Agreements
- InPharma AS
- Rosemont Pharmaceuticals
- Bristol-Myers Squibb Medical Imaging
- Laureate Pharma
- Holopack Verpackungstechnik GmbH
- Oncology Therapeutics Network, J.V
- Dow Chemical
- Financials
- Fiscal 2006
- First Quarter of 2007
- Funding
- Draxis Health
- Draximage Sestamibi
- Cardiac Imaging with Tc-99m Sestamibi
- Technetium Generators
- European Entry
- Infecton
- Other New Product Opportunities
- MI Alliances
- Isotope Products Laboratories
- Bristol-Myers Squibb
- Bracco
- Carestream Health (Kodak Health Group)
- Kodak Molecular Imaging Products
- In-Vivo Imaging Systems
- In-Vivo Multispectral
- In-Vivo FX Pro
- In-Vivo FX and F systems
- Kodak Image Station Systems
- Image System 4000MM Pro
- Kodak In Vitro Molecular Imaging Systems
- Gel Logic 2200
- Gel Logic 1500
- Gel Logic 200
- Gel Logic 100
- Imaging Software and Agents
- Kodak MI Software, Regulatory Edition
- Kodak X-Sight Imaging Agents
- EPIX PHARMACEUTICALS
- Drug Discovery and Development
- Vasovist
- EP-2104R
- Agreements
- GlaxoSmithKline
- Amgen
- Cystic Fibrosis Foundation Therapeutics
- Bayer Schering Pharma
- Siemens Medical Solutions
- Philips Medical Systems
- GE Healthcare
- Target Visual Technology
- EP-2104R
- Financials
- First Quarter of Fiscal 2007
- Fluoropharma
- Product Pipeline
- CardioPET
- Bfpet And Vasopet
- Market Opportunity
- Funding
- Gamma Medica
- Clinical Imaging Systems
- LumaGEM 3200S
- LumaGEM Study
- Agreement to acquire Advanced Molecular Imaging
- FLEX Triumph Preclinical Imaging Systems
- Improvements added to the 2nd generation FLEX Triumph System
- X-O
- X-PET
- X-SPECT
- Agreements
- Johns Hopkins University
- Siemens
- Funding
- GE HEALTHCARE
- GE Healthcare Diagnostic Imaging's Molecular Imaging Activities
- Preclinical Imaging Products
- eXplore Vista
- eXplore Vista PET/CT
- eXplore Locus in vivo MicroCT
- eXplore Locus Ultra Pre-Clinical CT
- eXplore Locus SP
- eXplore Optix
- Clinical Imaging Products
- Discovery PET/CT Systems
- Discovery Dimension
- PET VCAR (Volume Computer-Assisted Reading)
- Infinia SPECT/CT Systems
- Infinia Hawkeye 4
- Other Nuclear Imaging Systems
- Xeleris 2
- Cyclotrons
- FASTlab
- Tracerlab
- Medical Diagnostics
- MI Products
- Myoview
- DaTSCAN
- Ceretec
- Optison Ultrasound Imaging Agent
- MI Licensing Agreement
- Mergers and Acquisitions
- Amersham
- IDX Systems Corporation
- Abbott's In Vitro Diagnostics Business
- Research and Development
- R&D Facilities
- Imanet
- Molecular Imaging Study Areas
- Alzheimer's Disease
- Cardiovascular Disease
- Novel MRI Contrast Agents
- Antibody Technology
- R&D Projects
- PET Imaging Agent to Track Angiogenesis in Cancer
- Research Agreements
- University of Pittsburgh
- Mayo Clinic and Gamma Medica
- Oxford University
- St Joseph's Hospital and Medical Center
- Roche
- Eli Lilly
- Stanford University School of Medicine
- Texas A&M University System
- National Cancer Institute
- University of Washington
- Montefiore Medical Center
- Affibody
- Isogenica
- Pieris Proteolab
- St Joseph's Hospital and Medical Center
- University of California, San Fransciso
- Beth Israel Deaconess Medical Center
- Applera
- Financials
- GE Healthcare Operating Results, 2002-2006 (US$ billion)
- Fiscal 2006
- First Quarter of Fiscal 2007
- Glaxosmithkline
- Research Agreements
- Aarhus University Hospitals
- Guerbet
- Combidex/Sinerem
- Research Areas
- Oncology
- Cardiovascular Disease
- Research Agreements
- Advanced Magnetics
- Financials
- 2007 First Quarter Sales and Outlook
- Fiscal 2006
- Hamamatsu Photonics
- Products
- Animal PET Scanner SHR-7700
- Aequoria
- Development of New Labelled Compounds
- Other Imaging Technologies
- RDOT: Reflectance Diffuse Optical Tomography (Optical CT*)
- Financials
- IBA (ION BEAM APPLICATIONS)
- Radiopharmaceuticals
- Radioisotopes Production
- Mergers and Acquisitions
- Bayer Schering Pharma AG's Radiopharmaceutical Operations
- Eastern Isotopes
- New Mexico Positron and Lubbock West Texas Positron
- Divestitures
- Scanditronix Magnet AB
- Financials
- Fiscal 2006
- Imaging Diagnostic Systems
- CTLM system
- Laser Imager for Lab Animals (LILA)
- Patents
- Kereos
- Product Pipeline
- R&D Collaborations
- Washington University
- Dow Chemical Company
- Bristol-Myers Squibb Medical Imaging (BMSMI)
- Philips Medical Systems
- Lightools Research
- MI Products
- Pan-A-See-Ya Panorama
- Illumatool Bright Light System
- Macro-Imaging System Plus
- Macrocyclics (Magnetic Resonance Solutions)
- Research and Development
- Research Agreements
- MDS Nordion
- University of Texas at Dallas
- Research Grants
- National Cancer Institute
- Mallinckrodt (Covidien)
- Products
- Computed Tomography Contrast Media
- Optiray
- Magnetic Resonance Contrast Media
- OptiMARK
- Radiopharmaceuticals
- Nuclear Oncology
- Nuclear Cardology
- Myoview
- Financials
- Fiscal 2006
- MDS NORDION
- Products
- Medical Isotopes and Radiopharmaceuticals
- Research Agreements
- University of Ottawa Heart Institute
- Avid Radiopharmaceuticals
- Bradmer Pharmaceuticals
- Molecular Insight Pharmaceuticals
- Macrocyclics
- Financials
- First Quarter of 2007
- Fiscal 2006
- Mediscience Technology
- Basis for Technology
- Initial Products
- CD-Ratiometer
- Compact Photonic Pill
- Funding
- Market Size
- Alliances
- Alfanix Technology
- Infotonics Technology Center
- City University of New York (CUNY)
- City College's Institute for Ultrafast Spectroscopy and Lasers
- Stokes Shift Emission Spectroscopy
- Milabs
- Products
- U-SPECT II Scanners
- Resolution - 0.35 mm in 3 dimensions (0.04 l)
- Dynamic 4D imaging
- MIR PRECLINICAL SERVICES
- MIR - Services
- Efficacy Testing
- Imaging
- Pharmacokinetics
- Pharmacodynamics
- Drug Efficacy Testing in Models of Rheumatoid Arthritis (Experimental)
- In Vitro Services
- Preclinical Consulting
- Validation of Clinical Imaging Technologies
- Model Development
- Evaluation of Imaging Contrast Agents
- Independent Research
- Imaging Systems
- Proprietary Technology
- In Vivo Caspase 3 Activation Assay
- Ef-luc Transgenic Mouse
- Agreements
- Emiliem
- Licensing Agreements
- Biophotonic Imaging - Xenogen
- Funding
- State of Michigan's 21st Century Jobs Fund
- SBIR Grant
- Facility
- Molecular Insight Pharmaceuticals
- Product Pipeline
- Zemiva
- Clinical Profile and Development
- Azedra
- Onalta
- Other Pipeline Product Candidates
- Oncology - Solazed
- Prostate Cancer
- Trofex (MIP-220)
- Cardiology - MIP-190
- Neurology - MIP-170D
- Acquisitions
- Radiopharmaceutical Manufacturing Facility
- Agreements
- Bayer Schering Pharma
- Novartis Pharma AG
- MDS Nordion
- Eastern Isotopes (Ion Beam Applications)
- Recent R&D Highlights
- Financials
- First quarter of 2007
- Molecular Insight Operational Guidance
- Patents
- Molecular Neuroimaging
- Clinical Ligand Innovation Program (CLIP)
- Clinical Imaging Site Coordination and Management (CLIC)
- MNI Resources and Capabilities
- Naviscan Pet Systems
- Products
- PEM Flex Solo II
- Agreements
- Mayo Clinic
- Funding
- Olympus
- In Vivo Imaging Systems
- IV100 Intravital Laser Scanning System
- OV100 Small Animal Imaging System
- Acquisitions and Alliances
- Single Molecule Fluorescence Spectroscopy - Evotec Technologies
- VisEn Medical
- Cangen Biotechnologies
- AntiCancer
- Philips Medical Systems
- MI Products
- Preclinical Imaging Systems
- Mosaic HP
- NanoSPECT/CT
- Clinical Products
- Precedence SPECT/CT Systems
- BrightView
- JETStream Workspace 3.0
- Gemini PET/CT Systems
- Additional New Product Offerings
- Gamma Cameras
- Agreements
- Bioscan
- MRI Research Facility
- Research Collaborations
- University Medical Center Hamburg-Eppendorf (UKE)
- MRI/PET Image Software Tool
- Organon
- BG Medicine
- Dartmouth College
- Bayer Schering Pharma AG
- CellPoint
- Kereos
- Epix Pharmaceuticals
- Financials
- First Quarter of Fiscal 2007
- Fiscal 2006
- Key Financial Data, 2004-2006
- Photometrics (Roper Scientific)
- Products
- Lumazone CM Manual Chemiluminescence System
- Lumazone CA Automated Chemiluminescence System
- Lumazone FM Manual Fluorescence System
- Lumazone FA Automated Fluorescence System
- Spectral Imaging System for Fluorescence Microscopy
- Positron
- Products
- mPower PET Scanner
- Agreements
- Dr. George Diamond - Cadenza Software
- Mayerick Corporation
- Funding
- Patents
- SA INSTRUMENTS
- Small Animal Monitoring and Gating Products
- Model 1025 Monitoring and Gating System
- Model 1025L Monitoring and Gating System
- Siemens Medical Solutions
- Products
- Clinical Imaging
- Biograph PET-CT Systems with TruePoint Technology
- TruePoint SPECT-CT Systems
- HD-PET
- Spect
- c.cam
- e.cam Signature Series
- Symbia S
- Clinical Applications
- syngo
- Preclinical Imaging
- Inveon
- microPET
- microCAT
- Petnet Solutions
- PET Biomarkers
- Research and Development
- Imaging Biomarker for Alzheimer's Disease Phase I Clinical Trial
- FL-thymidine (FLT)
- Serum HER-2/neu
- Ultrasound - Liver Fibrosis Markers
- MR Imaging - Magnetic Nanoparticles
- IT Integration
- Prototype Hybrid MRI-PET Imaging System
- Siemens' Molecular Imaging Biomarkers Research Facility
- Abu Dhabi - First Molecular Imaging Centre
- Research Agreements
- Wyeth Pharmaceuticals
- University of Texas M. D. Anderson Cancer Center
- Center for Molecular Imaging Research (CMIR)
- Cytogen and University Hospitals of Cleveland
- VisEn Medical
- Commissariat l'Energie Atomique
- Emory University
- Licensing Agreements
- Cleveland Clinic
- Acquisitions
- Bayer Diagnostics and Diagnostic Products Corporation
- CTI Molecular Imaging
- Financials
- Fiscal 2006
- Fiscal 2007
- First Quarter of Fiscal 2007
- Second Quarter of Fiscal 2007
- Spectrum Dynamics
- Products
- D-SPECT Cardiac Imaging System
- D-SPECT Clinical Trials
- Future Products
- D-SPECT Hybrid CT
- TK SIGNAL
- Funding
- Research Projects
- Radioactive Tracers
- Ultraspect
- Products
- Xpress.cardiac
- Xact.bone
- Xpress.bone
- Funding
- Visen Medical
- Animal Imaging Products
- Optical Probes
- MMPSense - Probes capable of visualising MMP activity in tumours and other sites of inflammation
- AngioSPARK - Probes capable of enabling prolonged in vivo observation
- AminoSPARK - Probes capable of enabling fluorescent tagging of target molecules
- ProSense
- AngioSense
- OsteoSense
- Superhance
- VivoTag
- Genhance
- Fluorescence Molecular Tomographic (FMT) Imaging System
- Clinical Product Development
- MI Alliances
- Merck
- Olympus
- Analogic
- Siemens
- Visualsonics
- Micro-ultrasound
- Vevo 770
- Applications
- Techniques
- Image-guided Injection
- Screening
- Blood Flow Analysis
- 3D Visualisation
- Agreements
- Bracco
- University of Virginia
- Wilex
- Agreements
- IBA Molecular
- Financial Results
- Zecotek Medical Systems
- PET-MRI Research Project - University of Washington
- Scintillation Crystals
- Silicon Photo-Multiplier
- OCT Light Source - University of British Columbia
- Funding
- Patent Applications
- Zygogen
- Z-Tag and Z-Lipotrack Zebrafish Technology
- Angiogenesis
- Anti-angiogenesis assay
- Pro-angiogenesis assay
- Neurodegeneration
- Thrombosis
- Lipid Metabolism
- Toxicity
- Predict QT Prolongation in heart-specific fluorescent zebrafish
- Cytochrome P450 3A Activity
- Target Validation
- Compound Screening
- Licensing Agreements
- University of Minnesota - Morpholino Antisense Technology
- DanioLabs - Z-Tag
- Selected Academic And Research Institutions
- United States
- Case Western Reserve University - NFCR Center for Molecular Imaging
- Camel
- City of Hope
- Beckman Research Institute
- Division of Molecular Medicine
- Division of Medical Oncology & Therapeutics Research
- Duke University
- Duke Comprehensive Cancer Center
- Center for Molecular and Biomolecular Imaging (CMBI)
- Pulse Shaping and Heterodyne
- Johns Hopkins University
- JHU - In Vivo Cellular Molecular Imaging Center (ICMIC)
- Development Projects
- Massachusetts General Hospital - Center for Molecular Imaging Research
- CMIR Programmes
- Clinical Discovery Program
- Mayo Clinic
- Patterns between MRI-detected tumours and contralateral tumours
- Mayo Clinic - Ramirez-Alvarado Lab (Protein Misfolding)
- Molecular Imaging of Alzheimer's Plaques
- Research Collaboration with Gamma Medica
- Memorial Sloan-Kettering Cancer Center
- PET Imaging Identifies Aggressive Kidney Cancers that Require Surgery
- Mount Sinai School of Medicine
- Combining Molecular Imaging Technologies To Stop/Prevent Heart Attacks
- National Institutes of Health
- National Cancer Institute
- Nigms - Exploratory Centres For The Development Of High Resolution Probes For Cellular Imaging
- Fluorescent Probes for Multiplexed Intracellular Imaging
- Sub-nm Dendrimer-Metal Nanoclusters as Ultrabright, Modular Targeted in vivo Single Molecule Raman and Fluorescence Labels
- Single-Molecule Fluorophores for Cellular Imaging
- Bioaffinity Nanoparticle Probes for Molecular/Cellular Imaging
- Probes for Quantitative Optical and Electron Microscopy
- Imaging Single Proteins In Vivo with Quantum Dots
- Light-Activated Gene Expression in Single Cells
- Library-Based Development of New Optical Imaging Probes
- Genetically Targetable Labels for Light and EM
- Purdue University
- New Imaging Approach Promises Insights into Multiple Sclerosis
- Stanford University
- Molecular Imaging Program at Stanford
- Research on PET and CT separately and in combination in managing patients with melanoma
- Center of Excellence for Cancer Early Detection
- Study findings - CT scans may reveal genetic activity of liver tumours
- Thomas Jefferson University
- Circulating Tumour Cells Predict How Hormone-Resistant Prostate Cancer Patients Fare
- Translational Genomics Research Institute (TGen)
- Alzheimer's Disease Study
- University of California
- University of California, Los Angeles (UCLA)
- Center for In Vivo Imaging in Cancer Biology
- UCLA - Department of Molecular and Medical Pharmacology
- Crump Institute for Molecular Imaging
- New Brain Imaging Compound Shows Promise For Earlier Detection of Alzheimer's Disease
- University of California, San Diego (UCSD)
- University of California, Davis
- Center for Molecular and Genomic Imaging (CMGI)
- Cherry Laboratory - CMGI
- University of Chicago
- CAD technology may prove beneficial for tumour detection by PET
- University of Michigan Health System
- University of Minnesota
- PET-CT is better for early detection of muscular lymphoma than CT alone
- University of Texas M.D. Anderson Cancer
- Center for Advanced Biomedical Imaging Research
- Department of Experimental Diagnostic Imaging
- Targeted Molecular Imaging of Cancer
- Washington University, St. Louis
- Mallinckrodt Institute of Radiology
- Optical Radiology Laboratory (ORL)
- Lewis Lab
- Center for Clinical Imaging Research
- Cardiovascular Magnetic Resonance Imaging Laboratories (CMRL)
- Siteman Center of Cancer Nanotechnology Excellence
- Nanoparticles can track cells deep within living organisms
- Canada
- McMaster Institute of Applied Radiation Sciences (McIARS)
- University of Toronto, Ontario
- Laboratory of Molecular Imaging and Targeted Radiotherapeutics
- Europe
- Belgium
- University Hospital of Lige
- Finland
- Kuopio University, A.I Virtanen Institute for Molecular Sciences
- France
- CEA
- SHFJ - First complete simulation of PET imaging scan of entire human body
- NeuroSpin
- CNRS / Universit VI Paris, Paris, France
- Targeted and Functional Ultrasound, Laboratoire dImagerie Paramtrique - UMR 7623
- CNRS / University Victor Segalen, Bordeaux
- Molecular and Functional Imaging: From Physiology to Therapy Technological Research Team
- Germany
- Technical University of Munich, Munich
- Fraunhofer Institute/Medical School, Hanover
- Italy
- University of Milan, Milan
- Centre of Excellence on Neurodegenerative Diseases
- Netherlands
- Netherlands Cancer Institute
- Department of Radiology
- Impact of preoperative contrast-enhanced MRI in patients eligible for breastconserving therapy: update on 325 patients15
- Benefit of semi-automatic volumetric measurement of extent of breast tumours from contrast-enhanced MRI
- Accurate extent definition of non-small cell lung tumours using pathology validated PET-CT
- Optimising functional imaging approaches in a preclinical setting; molecular imaging in mice
- Sweden
- Uppsala University
- Karolinska Institutet, Uppsala, Sweden
- Department of Geriatric Medicine, Neurotec and Uppsala PET Centre / Imanet
- Collaboration with AstraZeneca
- United Kingdom
- Cancer Research UK
- Imperial College of Science, Technology and Medicine, London,
- Neurology Group, MRC Clinical Sciences Centre, Hammersmith Hospital
- Oxford University - Centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB)
- University of Durham
- Department of Chemistry
- University of Manchester - Wolfson Molecular Imaging Centre,
- University of Cambridge - Wolfson Brain Imaging Centre
- University of Edinburgh, Edinburgh
- Shefc Brain Imaging Centre For Scotland, West Of Scotland Radionuclide Dispensary, And Institute Of Neurological Sciences Glasgow
- ASIA
- Japan
- National Institute of Radiological Sciences - Molecular Imaging Center
- MIC Diagnostic Imaging Group
- Molecular Diagnosis Team
- Biomolecule Team
- MIC - Molecular Neuroimaging Group
- Molecular Neurobiology Team
- System Neurochemistry Team
- Molecular Probe Group
- Probe Research Team
- Biophysics Group
- MR Molecular Imaging Team
- Biosignal Physiology Team
- Imaging Analysis Team
- Imaging Physics Team
- Australia
- Austin Hospital, Melbourne
- Study - Amyloid Imaging in the Differential Diagnosis of Dementia
- University of Sydney, Sydney
- Academic Research Institute /Industry Collaborations
- References
- Report Methodology
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
PRINT/CD-ROM:Despatched within 1 to 2 working days.
Related Products
Recently Viewed Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories

















